Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$51.45
*  
0.78
 negative 
1.54%
Get TEVA Alerts
*Delayed - data as of Apr. 22, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    TEVA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Is Biogen (BIIB) Poised to Beat Earnings Estimates? - Analyst Blog
4/22/2014 6:05:01 PM - Zacks.com

Mylan: Court Denies Injunction Against Generic Version Of Copaxone
4/18/2014 10:50:00 PM - RTT News

Teva Settles Patent Litigation With Pfizer On Celebrex - Quick Facts
4/17/2014 8:45:00 AM - RTT News

Cramer's Lightning Round - I Was Too Bullish On LinkedIn (4/15/14)
4/16/2014 6:06:00 AM - Seeking Alpha

Regulatory Update from Impax - Analyst Blog
4/15/2014 4:55:01 PM - Zacks.com

Albany Molecular Aspires To Grow Revenue Five-Fold In As Many Years
4/15/2014 10:22:00 AM - Seeking Alpha

The 20 Best Value Bond Trades With Maturities Of 10 Years Or More
4/11/2014 1:19:00 AM - Seeking Alpha

Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha

Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick
4/10/2014 12:27:00 AM - Seeking Alpha

Critical Shortage Of Injectables Create Opportunity For Drugmakers
4/9/2014 4:46:00 PM - Seeking Alpha

Teva to Launch Generic Lovaza - Analyst Blog
4/9/2014 4:45:01 PM - Zacks.com

FDA OKs Teva's Launch Of Generic Lovaza Capsules In U.S - Quick Facts
4/8/2014 9:03:00 AM - RTT News

Teva Seeks to Delay Generic MS Drug
4/7/2014 12:05:00 PM - Dow Jones Business News

Teva Asks Supreme Court To Delay Possible Release of Generic Copaxone
4/7/2014 11:39:00 AM - Dow Jones Business News

Venture Capitalist Ran Nussbaum Brings Big Finance To Little Biotechs
4/4/2014 8:31:00 AM - Seeking Alpha

Judge Upholds Validity of Eli Lilly Patent
3/31/2014 8:12:00 PM - Dow Jones Business News

Markets Rally on Last Day of First Quarter
3/31/2014 4:25:00 PM - Knobias

Stocks Remain Sharply Higher at Midday on Yellen's Dovish Comments
3/31/2014 1:26:00 PM - Knobias

CORRECTION: Midday Update: Stocks Buoyed By Stimulus Expectations
3/31/2014 12:31:11 PM - MT Newswires

Midday Update: Stocks Buoyed By Stimulus Expectations
3/31/2014 12:12:57 PM - MT Newswires

Supreme Court to Review Teva Appeal in Copaxone Patent Case
3/31/2014 10:52:00 AM - Dow Jones Business News

Teva Pharmaceutical Industries (TEVA) Has Spiked To A New High
3/31/2014 9:42:00 AM - RTT News

BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month
3/31/2014 3:45:00 AM - Seeking Alpha

10 Healthcare Dogs Prescribe 6% To 16% March Upsides
3/26/2014 5:59:00 PM - Seeking Alpha

Antares Pharma: Recent Sell-Off Provides Great Entry Point
3/26/2014 10:16:00 AM - Seeking Alpha